tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Akeso, Inc. (HK:9926)
:9926
Hong Kong Market
9926
Akeso, Inc.
RESEARCH TOOLSreports

Akeso, Inc. (9926) Stock News & Sentiment

Compare
40 Followers
Akeso Details Long-Term MAb Contract Manufacturing and Demand Assumptions
Premium
Company Announcements
Akeso Details Long-Term MAb Contract Manufacturing and Demand Assumptions
7d ago
Akeso Restructures MAb Manufacturing Deal as Joint Venture Becomes Connected Transaction
Premium
Company Announcements
Akeso Restructures MAb Manufacturing Deal as Joint Venture Becomes Connected Transaction
1M ago
Akeso’s Innovative Drugs Included in China’s 2025 NRDL
Premium
Company Announcements
Akeso’s Innovative Drugs Included in China’s 2025 NRDL
2M ago
Akeso, Inc. Advances Cancer Treatment with New Phase I Study on AK137
Premium
Company Announcements
Akeso, Inc. Advances Cancer Treatment with New Phase I Study on AK137
3M ago
9926
Akeso, Inc. Launches Promising Phase II Study for NSCLC Treatment
Premium
Company Announcements
Akeso, Inc. Launches Promising Phase II Study for NSCLC Treatment
3M ago
9926
Akeso, Inc. Advances Cancer Treatment with Promising AK146D1 Study
Premium
Company Announcements
Akeso, Inc. Advances Cancer Treatment with Promising AK146D1 Study
3M ago
9926
Akeso’s New Phase II Study on Advanced Pancreatic Cancer: A Potential Game-Changer?
Premium
Company Announcements
Akeso’s New Phase II Study on Advanced Pancreatic Cancer: A Potential Game-Changer?
3M ago
9926
More HK:9926 News >

9926 News on the Web

Akeso Details Long-Term MAb Contract Manufacturing and Demand Assumptions
TipRanks News
Bullish
Akeso announces NMPA acceptance of second NDA for gumokimab
TipRanks News
Bullish
Akeso's Cadonilimab Outperforms PD-1 Inhibitors In Gastric Cancer; Stock Up
rttnews
Bullish
Akeso Secures NMPA Label Update For Ivonescimab With Dual Survival Benefits In NSCLC
rttnews
Bullish
Akeso Presents Positive Data Of Cadonilimab Regimen In Resectable Gastric Cancer At ESMO Asia 2025
rttnews
Neutral
Akeso’s Innovative Drugs Included in China’s 2025 NRDL
TipRanks News
Neutral
Akeso, Inc. Advances Cancer Treatment with New Phase I Study on AK137
TipRanks News
Neutral
Akeso’s Phase 3 Trial: A Potential Game-Changer in NSCLC Treatment
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HK:9926’s Media Buzz Sentiment?
Currently, no data Available
What is HK:9926’s weekly average amount of articles?
Currently, no data Available
What is HK:9926’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
HOCPFHOYA
HVOOpen Orphan Plc
CRDFCardiff Oncology
QNCXQuince Therapeutics
KRROKorro Bio
Showing the stocks with the most bullish news sentiment over the past week